aurora cannabis

Aurora Cannabis products unavailable in Germany until further notice

Aurora Cannabis’ medical marijuana products are temporarily unavailable in Germany pending a review by health authorities of “a proprietary step” in the Alberta company’s production process, a spokesperson confirmed to Marijuana Business Daily. MJBizDaily corroborated the products’ unavailability with several German pharmacies “until further notice.” According to the pharmacies, the reason is related to a […]

Read More

British Columbia chamber lobbies province over craft cannabis cultivation

The Chamber of Commerce in British Columbia wants the province to adopt policies encouraging craft cannabis businesses to join the regulated market, including allowing proprietors to keep their doors open during the transition into the legal fold. The proposals were among a number of policies the chamber asked Public Safety Minister Mike Farnworth to consider during […]

Read More

What businesses need to know about exporting irradiated medical cannabis to Germany

By now, everyone knows that to export medical cannabis to Germany, which is by far the largest importer of medical cannabis flower in the world, achieving European Union Good Manufacturing Practice (GMP) is a prerequisite. But beyond getting that certification, certain quality requirements could have huge implications if they are not considered and integrated into a business’ […]

Read More

Canadian cannabis group appeals to Trudeau to help fix industry challenges

An industry group representing Canada’s biggest cannabis companies is appealing to Prime Minister Justin Trudeau to help address some of the industry’s most persistent challenges. In a letter sent to Trudeau on Nov. 9 and made public Thursday night, the Cannabis Council of Canada highlighted a number of areas in need of improvement, including a […]

Read More

Aurora Cannabis ceases construction at Alberta, Denmark facilities as losses widen

Aurora Cannabis is ceasing construction at its large second-phase facility in Denmark and deferring most of the final construction at its Aurora Sun facility in Medicine Hat, Alberta, as the company’s losses widened substantially in the quarter. The moves would save Aurora a combined 190 million Canadian dollars ($143 million) in the coming year. Aurora said the […]

Read More

Cannabis extraction firm MediPharm seeks Nasdaq listing

Barrie, Ontario-based cannabis extraction company MediPharm Labs has applied to list its shares on the Nasdaq amid a heightened period of volatility for marijuana stocks in North America. If approved for trading, MediPharm would join a growing list of Canadian cannabis companies turning to the top U.S. stock exchanges to tap the globe’s largest pool of institutional […]

Read More

‘No longer a shortage,’ Canadian cannabis industry group declares

The shortage of cannabis that plagued businesses in the early months of legalization is over, according to an industry group representing Canada’s biggest marijuana producers. “There is ample supply of cannabis for the adult recreational market,” Cannabis Council of Canada wrote in an open letter to Ontario Premier Doug Ford, who cited the shortfall when […]

Read More

Danish medical cannabis sales stall on supply, price issues

Denmark’s medical cannabis pilot program saw virtually no quarter-over-quarter growth in the first half of 2019, according to new Danish Health Authority data. Experts say the market was hampered by a combination of prohibitively priced imports and supply issues. In the second quarter, 1,844 cannabis prescriptions were redeemed by 1,045 patients under Denmark’s four-year medical […]

Read More

German cannabis firm Demecan secures 7 million euros in financing

German medical cannabis company Demecan has secured 7 million euros ($7.6 million) in financing to expand production in Europe’s largest medical market. The fresh capital – from btov Partners, a European venture capital firm, and a German single family office – comes as international companies establish footholds in the important European Union market. Constantin von der Groeben, Demecan’s managing director, […]

Read More

‘Groundbreaking’: 48North’s purchase of US cannabis company signals major shift by TSX Venture Exchange

The TSX Venture Exchange (TSXV) appears to be easing its opposition toward Canadian cannabis companies buying U.S. marijuana businesses. The move would mark a major shift for the Canadian exchange and could open the door to more cross-border acquisitions – provided the deals meet strict conditions. The apparent change in stance comes after a Canadian […]

Read More